About: Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $13.86 (-2.81%)
DRTS NASDAQ Alpha Tau Medical Ltd
Alpha Tau Medical Ltd share price
DRTS price activity
Last Price
$13.860
Change (24hr)
-0.40 USD (-2.81%)
Volume
216.02K
Volume (4w avg)
-
Open
$14.11
Day Range
$13.86 - $14.11
Previous Close
$14.26
Last Trade
13 Oct, 3:33 pm GMT+0
Delayed
13 Oct, 3:33 pm GMT+0
DRTS price performance
Delayed
13 Oct, 3:33 pm GMT+0
DRTS Market Signals